Table 2.

Variants Identified in Sequencing of KCNJ18 in the Current Study and Their Genotypic Distribution in Participants With TPP, Participants With Graves Disease Without TPP, and Healthy Control Subjects

TPP (n = 13)Graves Diseasea (n = 8)Control (n = 8)
SNV123456789101112131234567812345678
SNV1116A>GR39Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV2119A>GR40H1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV3167A>CA56Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV4298G>AV100I1/11/11/11/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV5433G>AG145S1/11/21/11/11/11/11/11/11/11/11/11/11/21/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV6745G>AI249V1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
TPP (n = 13)Graves Diseasea (n = 8)Control (n = 8)
SNV123456789101112131234567812345678
SNV1116A>GR39Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV2119A>GR40H1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV3167A>CA56Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV4298G>AV100I1/11/11/11/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV5433G>AG145S1/11/21/11/11/11/11/11/11/11/11/11/11/21/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV6745G>AI249V1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2

Variant numbers: 1, major allele; 2, minor allele.

a

Graves disease without TPP episode.

Table 2.

Variants Identified in Sequencing of KCNJ18 in the Current Study and Their Genotypic Distribution in Participants With TPP, Participants With Graves Disease Without TPP, and Healthy Control Subjects

TPP (n = 13)Graves Diseasea (n = 8)Control (n = 8)
SNV123456789101112131234567812345678
SNV1116A>GR39Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV2119A>GR40H1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV3167A>CA56Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV4298G>AV100I1/11/11/11/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV5433G>AG145S1/11/21/11/11/11/11/11/11/11/11/11/11/21/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV6745G>AI249V1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
TPP (n = 13)Graves Diseasea (n = 8)Control (n = 8)
SNV123456789101112131234567812345678
SNV1116A>GR39Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV2119A>GR40H1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV3167A>CA56Q1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2
SNV4298G>AV100I1/11/11/11/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV5433G>AG145S1/11/21/11/11/11/11/11/11/11/11/11/11/21/21/11/11/11/11/11/11/11/11/11/11/11/11/11/11/1
SNV6745G>AI249V1/11/11/11/11/11/11/11/11/11/11/11/11/11/11/21/11/11/11/11/12/22/21/11/11/11/11/21/11/2

Variant numbers: 1, major allele; 2, minor allele.

a

Graves disease without TPP episode.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close